Table 1 Participant clinical characteristics of patients with PCOS and controls
From: Autophagy Proteins and clinical data reveal the prognosis of polycystic ovary syndrome
Variable (n) | PCOS (n = 33) | Control (n = 7) | p-value |
|---|---|---|---|
Age (year) | 25.8 (3.1) | 27.0 (2.9) | 0.37 |
BMI (kg/m2) | 23.9 (21.1, 27.3) | 20.8 (19.5, 22.0) | 0.03 |
AMH (ng/mL) | 9.0 (4.1) | 1.8 (1.1) |  < 0.01 |
FSH (mIU/mL) | 7.2 (5.9, 7.9) | 5.3 (5.2, 6.3) | 0.02 |
LH (mIU/mL) | 11.8 (4.3) | 5.3 (0.6) |  < 0.01 |
LH/FSH ratio | 1.8 (0.7) | 1.0 (0.1) |  < 0.01 |
T (ng/dL) | 42.1 (17.6) | 24.7 (11.4) | 0.02 |
FPG (mmol/L) | 5.2 (0.5) | 4.5 (0.4) |  < 0.01 |
Insulin (mIU/mL) | 16.2 (9.77, 25.84) | 7.34 (6.49, 12) | 0.015 |
HOMA-IR | 3.89 (2.35, 6.29) | 1.74 (1.29, 2.16) | 0.003 |
ET (mm) | 4.0 (1.4) | 9.6 (0.8) |  < 0.01 |
Live birth (%) | 20(60.6) | 7(100) | 0.043 |
Adverse gestation (%) | 13(39.4) | 0(0) | Â |